What is the recommended dose of adrenaline (epinephrine) for treating anaphylaxis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Adrenaline Dosing for Anaphylaxis

For anaphylaxis treatment, administer epinephrine (adrenaline) at a dose of 0.01 mg/kg (maximum 0.5 mg) intramuscularly in the anterolateral thigh, with specific dosing of 0.3-0.5 mg for adults and children ≥30 kg, and 0.01 mg/kg (maximum 0.3 mg) for children <30 kg. 1

Dosing Guidelines by Weight

  • Adults and children ≥30 kg (66 lbs):

    • Dose: 0.3-0.5 mg epinephrine
    • Concentration: 1:1000 (1 mg/mL)
    • Volume: 0.3-0.5 mL
    • Route: Intramuscular injection in the anterolateral thigh
    • Frequency: Can be repeated every 5-10 minutes as necessary 1, 2
  • Children <30 kg (66 lbs):

    • Dose: 0.01 mg/kg, up to maximum 0.3 mg
    • Concentration: 1:1000 (1 mg/mL)
    • Volume: 0.01 mL/kg, up to maximum 0.3 mL
    • Route: Intramuscular injection in the anterolateral thigh
    • Frequency: Can be repeated every 5-10 minutes as necessary 1, 2

Administration Considerations

Route of Administration

The intramuscular route in the anterolateral thigh is strongly preferred over subcutaneous administration. While the FDA label mentions both routes 2, evidence indicates that intramuscular administration in the mid-outer thigh provides more rapid and reliable absorption 3, 4.

Injection Site

The mid-outer thigh (vastus lateralis muscle) is the recommended injection site 3, 1. Do not inject into buttocks, digits, hands, or feet as this may lead to poor absorption or tissue damage 2.

Timing

Prompt administration of epinephrine is critical for preventing fatal outcomes. Delays in administration are associated with increased mortality 3, 4. Epinephrine should be given immediately upon recognition of anaphylaxis 3, 1.

Special Populations

Infants and Young Children

The clinical criteria for anaphylaxis have not been validated in infants 3. For very young children weighing less than 15 kg, standard auto-injector needle lengths may be too long, potentially resulting in intravascular injection 5. Consider using weight-appropriate devices when available.

Obese Patients

In obese patients, standard auto-injector needle lengths may be too short to reach muscle tissue 5. In such cases, ensure proper injection technique or consider alternative delivery methods to achieve intramuscular administration.

Monitoring and Follow-up

After administering epinephrine:

  • Monitor the patient closely for at least 4-6 hours for potential biphasic reactions 1
  • Position the patient supine with legs elevated if hypotensive 1
  • Be prepared to administer a second dose if symptoms persist or worsen (6-19% of pediatric patients require a second dose) 1
  • Activate emergency response system (call 911) for transport to an emergency department 3, 1

Common Pitfalls to Avoid

  1. Delayed administration: Failure to inject epinephrine promptly is a major contributor to anaphylaxis fatalities 4.
  2. Incorrect route: Using subcutaneous instead of intramuscular injection can delay onset of action 4.
  3. Inappropriate injection site: Injecting into digits, hands, feet, or buttocks rather than the thigh can lead to poor absorption or complications 2.
  4. Underdosing: Particularly in adults, using pediatric doses can result in inadequate treatment.
  5. Fear of side effects: Concern about adverse effects should not prevent timely administration of epinephrine in anaphylaxis, as the benefits far outweigh the risks 3, 4.

Remember that epinephrine is the cornerstone of anaphylaxis management, and no other medication has similar life-saving pharmacologic effects in multiple organ systems 4. While adjunctive therapies like antihistamines and corticosteroids may be used, they should never delay or replace epinephrine administration 1.

References

Guideline

Anaphylaxis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Epinephrine (adrenaline) in anaphylaxis.

Chemical immunology and allergy, 2010

Research

Epinephrine, auto-injectors, and anaphylaxis: Challenges of dose, depth, and device.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.